OrbusNeich Medical Group Holdings (FRA:Q8T) Ending Cash Position : €57.0 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings Ending Cash Position?

OrbusNeich Medical Group Holdings's Ending Cash Position for the quarter that ended in Dec. 2024 was €57.0 Mil.

OrbusNeich Medical Group Holdings's quarterly Ending Cash Position declined from Dec. 2023 (€53.4 Mil) to Jun. 2024 (€28.4 Mil) but then increased from Jun. 2024 (€28.4 Mil) to Dec. 2024 (€57.0 Mil).

OrbusNeich Medical Group Holdings's annual Ending Cash Position declined from Dec. 2022 (€81.8 Mil) to Dec. 2023 (€53.4 Mil) but then increased from Dec. 2023 (€53.4 Mil) to Dec. 2024 (€57.0 Mil).

OrbusNeich Medical Group Holdings Ending Cash Position Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings Ending Cash Position Chart

OrbusNeich Medical Group Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

12.42

155.66

81.79

53.42

56.97

OrbusNeich Medical Group Holdings Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial					81.79	69.70	53.42	28.37	56.97

OrbusNeich Medical Group Holdings Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

OrbusNeich Medical Group Holdings's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	55.63	+	1.343
	=	57.0

OrbusNeich Medical Group Holdings's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	29.162	+	27.811
	=	57.0

OrbusNeich Medical Group Holdings Ending Cash Position Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

OrbusNeich Medical Group Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

06929:Hong Kong

Address

3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG

Website

https://www.orbusneich.com

OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines